Related Experiment Videos
Calmodulin dependence of NFkappaB activation
K Hughes1, A Antonsson, T Grundstrøm
1Department of Cell and Molecular Biology, Umeå University, Sweden.
FEBS Letters
|January 7, 1999
Summary
Calmodulin (CaM) antagonists block the activation of the transcription factor NF-kappaB by preventing the phosphorylation of its inhibitor, IkappaB. This suggests CaM plays a role in IkappaB phosphorylation during NF-kappaB signaling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The transcription factor NF-kappaB controls gene expression and is regulated by inhibitory IkappaB proteins.
- NF-kappaB activation involves the phosphorylation and degradation of IkappaB.
- Calmodulin (CaM) is a crucial Ca2+ sensor regulating diverse cellular processes.
Purpose of the Study:
- To investigate the role of Calmodulin (CaM) in the activation pathway of NF-kappaB.
- To determine if CaM antagonists affect NF-kappaB activation and the underlying molecular mechanisms.
Main Methods:
- Treatment of cells with Calmodulin (CaM) antagonists.
- Analysis of NF-kappaB activation.
- Assessment of IkappaB phosphorylation levels.
Main Results:
- Several CaM antagonists were found to inhibit NF-kappaB activation.
- This inhibition was attributed to the prevention of inducible IkappaB phosphorylation.
- The results indicate a role for CaM in the phosphorylation of IkappaB.
Conclusions:
- Calmodulin (CaM) appears to be involved in the phosphorylation of IkappaB.
- This finding provides new insights into the regulatory mechanisms of NF-kappaB activation.
- Understanding CaM's role may elucidate critical steps in NF-kappaB signaling.